All News

Cancer survivor tries to actively practice gratitude during stressful holiday season and life's changes.

In an interview with CURE, Postow, a medical oncologist specializing in melanoma at Memorial Sloan Kettering Cancer Center, discussed the impressive efficacy seen with combining BRAF and MEK inhibitors for patients with melanoma.

A new drug, GSK2857916, was granted a breakthrough therapy designation by the FDA to treat patients who have relapsed or refractory multiple myeloma, according to GlaxoSmithKline (GSK), the manufacturer of the agent.

Recommendations made by patients living with MBC and health care providers who are cancer survivors will soon be disseminated throughout the health care system.

Akron, Ohio's best kept secret may revolutionize breast cancer treatment.

How does someone who is adopted put together the pieces of their genetic puzzle, especially after a cancer diagnosis?

After being a cancer caregiver, it is important to take time to recover and have hope for the future.

Two-time cancer survivor provides insight as a caregiver.

The Coleman Supportive Oncology Collaborative, a group of professionals from academic, community and public cancer centers and hospice providers, addresses gaps in oncology care delivery.

Two-time cancer survivor offers ideas to reduce clutter, even through difficult times.

When my oncologist asked me if I would consider being in a clinical trial, my answer was immediate.

You walk in and the entire staff yells your name, al la “Norm” of Cheers fame

Four companies drew the ire of the Food and Drug Administration this week for claiming that their marijuana-derived products can treat or cure cancer. The agency issued letters of warning, and threatened punitive action if the companies do not correct the violations.

A study presented at the 2017 Palliative and Supportive Care in Oncology Symposium examined the effects of early-integrated palliative care on patients with advanced/incurable lung or non-colorectal gastrointestinal cancers.

During the holiday season, cancer patients get a lot of well-intentioned but unhelpful advice. Here's how to make it stop.

Two-time cancer survivor offers ways to work toward happy.

Calquence (acalabrutinib) was granted an accelerated approval by the FDA to treat adult patients with mantle cell lymphoma (MCL) following at least one prior therapy. The approval was based on objective response rates (ORR) in a single-arm trial.

An advanced lung cancer diagnosis can be extremely stressful for patients and their loved ones, but a couples-based mindfulness intervention may be able to help.

Cancer is filled with a ton of crazy terms that doctors like me often have to translate.

The role of being a healthy caregiver involves knowing when to put the oxygen mask on.

Surviving cancer just got easier, thanks to these angels.

More patients with non-small cell lung cancer (NSCLC) should be evaluated and referred to clinical trials, especially those who may have molecular abnormalities, says Victoria M. Villaflor, M.D.

For those with hepatitis B, taking an aspirin once a day could reduce the risk of getting liver cancer.

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

If approved, the new indication would make frontline Avastin available in combination with carboplatin and paclitaxel, followed by Avastin alone, for women with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. The FDA is expected to render a decision on the sBLA by June 25, 2018.

What happens when the hustle, bustle, attention and care of active treatment end? Survivor shares what helped.

A cancer survivor weighs his losses and gains.

While the use of Jakafi (ruxolitinib) is firmly rooted in the treatment paradigm for patients with myelofibrosis, other novel agents, such as momelotinib and pacritinib are also gaining the interest of researchers in the field.